KSE - Delayed Quote KRW

Chong Kun Dang Pharmaceutical Corp. (185750.KS)

Compare
89,100.00 +100.00 (+0.11%)
At close: 3:30:30 PM GMT+9

Research Analysis

Revenue vs. Earnings

Revenue 408.48B
Earnings 21.5B
Q4'23
Q1'24
Q2'24
Q3'24
0
100B
200B
300B
400B
500B
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Analyst Price Targets

136,190.47
147,142.86 Average
89,100.00 Current
171,428.58 High

Earnings Estimate

Currency in USD Current Qtr. (Dec 2024)Next Qtr. (Mar 2025)Current Year (2024)Next Year (2025)
No. of Analysts ----68
Avg. Estimate 008,576.357,673.33
Low Estimate 008,345.717,052.38
High Estimate 009,084.768,486.67
Year Ago EPS ----15,908.578,576.35

Revenue Estimate

Currency in KRW Current Qtr. (Dec 2024)Next Qtr. (Mar 2025)Current Year (2024)Next Year (2025)
No. of Analysts 3488
Avg. Estimate 409.07B393.62B1.56T1.67T
Low Estimate 404.5B387.2B1.55T1.65T
High Estimate 411.5B399B1.58T1.69T
Year Ago Sales 501.45B353.45B1.67T1.56T
Sales Growth (year/est) -18.42%11.37%-6.47%6.79%

EPS Trend

Currency in USD Current Qtr. (Dec 2024)Next Qtr. (Mar 2025)Current Year (2024)Next Year (2025)
Current Estimate 008,576.357,673.33
7 Days Ago 007,696.797,557.26
30 Days Ago 007,364.637,680.83
60 Days Ago 007,364.637,680.83
90 Days Ago 007,077.967,631.75

EPS Revisions

Currency in USD Current Qtr. (Dec 2024)Next Qtr. (Mar 2025)Current Year (2024)Next Year (2025)
Up Last 7 Days ----22
Up Last 30 Days ----13
Down Last 7 Days --------
Down Last 30 Days ----12

Growth Estimates

Current Qtr.Next Qtr.Current YearNext Year
185750.KS -----46.09%-10.53%
S&P 500 5.00%12.00%2.10%12.20%

Related Tickers